East Ventures Invests Seed Funding to Nusantics, a Startup in Genomics

Nusantics, a local startup in the field of genomics technology, received seed funding from a venture capital company, East Ventures. However, the value of the funding was not stated.

These funds will be used to accelerate the company’s mission to become a pioneer in the biogenome industry in Indonesia. Nusantics focuses on developing and applying various genomics and microbiome research to meet the needs of a healthy and sustainable lifestyle.

The startup, which was established in 2019, consists of Sharlini Eriza Putri (engineer graduated from the Bandung Institute of Technology and Imperial College London), Vincent Kurniawan (engineer graduated from CSPU-Pomona, United States), and Revata Utama (scientist in the field of biotechnology from National University of Singapore).

They believe that understanding life (life science), specifically about microbiomes, is one of the most important factors in providing sustainable solutions to a variety of human problems.

“Developments in technology have made us realize that all living things on earth are interdependent with the microbiome in their bodies,” said Sharlini, who is Co-founder and CEO of Nusantics.

According to Sharlini, besides having an important role in creating healthy ecosystems, the microbiome is also one of the factors behind the occurrence of a global pandemic. “Nusantics believes that understanding the genetics of this microbiome is very important as the key to our survival and the earth,” Sharlini said.

Through Microbiome, Nusantics Will Assist Consumers in Choosing Products for Their Bodies

As a technology-based company, Nusantics will focus on developing and implementing a variety of genomics and microbiome research to be able to meet the needs of a healthy and sustainable lifestyle.

Microbiome, simply, is a complex ecosystem consisting of microorganisms such as bacteria, viruses, to fungi that live on the surface and in the bodies of all living things, including humans. Every person has a unique microbiome profile that plays a role in their immune system.

Armed with an understanding of the microbiome’s profile, Nusantics believes that it can help consumers to choose the most appropriate and needed product for their bodies. Microbiome analysis can also help industry and consumers consider the impact of each of their decisions on the health and sustainability of nature.

As the first local startup to do microbiome profile analysis, Nusantics will introduce this new thing to consumers in the lifestyle industry, through skin analysis services.

Various researches in the field of genomics show that healthy skin is skin that has a diverse and balanced microbiome. However, limited knowledge about the role of microbiome balance makes it difficult for consumers to find skin care products that are suitable for their individual needs.

The Company Will Help Consumers to Avoid Mistakes in Choosing Beauty Products

For your information, increasing skin care trends make Indonesia a big market for beauty products and treatments. The Beauty Market Survey released by Nielsen and EuroMonitor stated that the value of the beauty market in Indonesia reached Rp 36 trillion in 2018 and around 31.7% of that value was contributed by skincare products.

Nusantics Co-founder and CEO Sharlini Eriza Putri said Nusantics provided a solution that could help consumers avoid mistakes in using skincare products.

“Microbiome plays an important role in creating healthy ecosystems, but it is also a major factor behind the occurrence of a global pandemic. Nusantics believes that understanding the genetics of this microbiome is very important as the key to our survival and the earth, “Sharlini said through an official statement Friday (3/20/2020).

Nusantics Co-founder and COO Vincent Kurniawan added that Nusantics collaborates with all stakeholders by offering added value that can be achieved together to create a balanced and sustainable business ecosystem.